Thrombophilia work-up and clinical outcomes in Indian patients with unprovoked venous and arterial thrombosis aged 18-50 years | BTVB Bioequivalence of von Willebrand factor-containing concentrates: implications for von Willebrand disease | BTVB Cardiovascular risk in hormone replacement therapy | BTVB Direct oral anticoagulants: does one dose fit all? Why, when and how testing | BTVB Cardiovascular risk profile evolution over 15 years: CV-PREVITAL vs Moli-sani Study | BTVB Launch of National Registry for Congenital Hematological Disorders in Palestine: Haemo-PAL | BTVB

This journal has not published any issues.

Impact Factor 2025

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

PO47 | VENOUS THROMBOEMBOLISM IN BREAST CANCER: INSIGHTS FROM A SINGLE-CENTER COHORT S. Kozhukhov, N. Dovganych | SI “NSC “The M. D. Strazhesko Institute of Cardiology, Clinical and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine; ²Cardio-Oncology Center, Kyiv, Ukraine

ICTHIC 2026

16-04-2026

https://doi.org/10.4081/btvb.2026.540

294

PDF: 92
Science and scientists under attack

Valerio De Stefano

23-05-2023

https://doi.org/10.4081/btvb.2023.80

751

PDF: 316
Science in Ukraine is “bleeding”

Giovanni de Gaetano

14-03-2023

https://doi.org/10.4081/btvb.2023.69

1180

PDF: 333
The metaphor of Ukrainian science "bleeding"

Gaetano Torlone

04-04-2023

https://doi.org/10.4081/btvb.2023.73

706

PDF: 328
A contribution from Umberto Veronesi Foundation

Chiara Tonelli

04-04-2023

https://doi.org/10.4081/btvb.2023.74

627

PDF: 356

1 - 5 of 5 items

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.